BIOMAT Database Logo BIOMAT Database Logo

IgM-antibody response to hepatitis C virus antigens in acute and chronic post-transfusion non-A, non-B hepatitis. 1991

K H Chau, and G J Dawson, and I K Mushahwar, and R A Gutierrez, and R G Johnson, and R R Lesniewski, and L Mattsson, and O Weiland
Experimental Biology Research, Abbott Laboratories, North Chicago, IL.

A specific IgM solid-phase enzyme-linked immunoassay for the diagnosis of a recent infection by hepatitis C virus (HCV) was developed. The assay utilizes a structural antigen encoded by sequences at the 5' end of HCV (core region) and non-structural (NS) antigens encoded by the NS-3 (33c) and NS-4 (c100-3) regions of the HCV genome. Serial serum samples from several clinically diagnosed post-transfusion non-A, non-B hepatitis patients were analyzed for anti-HCV IgM. This antibody was frequently but transiently detected. Anti-HCV core IgM was more frequently detected than anti-c100-3 or anti-33c IgM. In individuals who resolved their HCV infection or progressed to chronicity, anti-HCV IgM was produced transiently at or near the onset of clinically diagnosed acute hepatitis.

UI MeSH Term Description Entries
D007075 Immunoglobulin M A class of immunoglobulin bearing mu chains (IMMUNOGLOBULIN MU-CHAINS). IgM can fix COMPLEMENT. The name comes from its high molecular weight and originally was called a macroglobulin. Gamma Globulin, 19S,IgM,IgM Antibody,IgM1,IgM2,19S Gamma Globulin,Antibody, IgM
D002908 Chronic Disease Diseases which have one or more of the following characteristics: they are permanent, leave residual disability, are caused by nonreversible pathological alteration, require special training of the patient for rehabilitation, or may be expected to require a long period of supervision, observation, or care (Dictionary of Health Services Management, 2d ed). For epidemiological studies chronic disease often includes HEART DISEASES; STROKE; CANCER; and diabetes (DIABETES MELLITUS, TYPE 2). Chronic Condition,Chronic Illness,Chronically Ill,Chronic Conditions,Chronic Diseases,Chronic Illnesses,Condition, Chronic,Disease, Chronic,Illness, Chronic
D004797 Enzyme-Linked Immunosorbent Assay An immunoassay utilizing an antibody labeled with an enzyme marker such as horseradish peroxidase. While either the enzyme or the antibody is bound to an immunosorbent substrate, they both retain their biologic activity; the change in enzyme activity as a result of the enzyme-antibody-antigen reaction is proportional to the concentration of the antigen and can be measured spectrophotometrically or with the naked eye. Many variations of the method have been developed. ELISA,Assay, Enzyme-Linked Immunosorbent,Assays, Enzyme-Linked Immunosorbent,Enzyme Linked Immunosorbent Assay,Enzyme-Linked Immunosorbent Assays,Immunosorbent Assay, Enzyme-Linked,Immunosorbent Assays, Enzyme-Linked
D006508 Hepatitis Antibodies Immunoglobulins raised by any form of viral hepatitis; some of these antibodies are used to diagnose the specific kind of hepatitis. Antibodies, Hepatitis
D006526 Hepatitis C INFLAMMATION of the LIVER in humans caused by HEPATITIS C VIRUS, a single-stranded RNA virus. Its incubation period is 30-90 days. Hepatitis C is transmitted primarily by contaminated blood parenterally and is often associated with transfusion and intravenous drug abuse. However, in a significant number of cases, the source of hepatitis C infection is unknown. Hepatitis, Viral, Non-A, Non-B, Parenterally-Transmitted,Parenterally-Transmitted Non-A, Non-B Hepatitis,PT-NANBH,Parenterally Transmitted Non A, Non B Hepatitis
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000208 Acute Disease Disease having a short and relatively severe course. Acute Diseases,Disease, Acute,Diseases, Acute
D000956 Antigens, Viral Substances elaborated by viruses that have antigenic activity. Viral Antigen,Viral Antigens,Antigen, Viral
D014758 Viral Core Proteins Proteins found mainly in icosahedral DNA and RNA viruses. They consist of proteins directly associated with the nucleic acid inside the NUCLEOCAPSID. Core Proteins, Viral,Major Core Protein,Major Core Proteins, Viral,Adenovirus Core Protein VII,Core Protein V,Core Protein lambda 2,Influenza Virus Core Proteins,Major Core Protein lambda 1,Major Core Protein lambda-1,Major Core Protein sigma 2,Major Core Protein sigma-2,OVP 19,Oncornaviral Protein P19,P30 Core Proteins,Viral Protein P19,Virus Core Proteins,Core Protein, Major,Core Proteins, P30,Core Proteins, Virus,Protein P19, Oncornaviral,Protein P19, Viral,Protein, Major Core,Proteins, P30 Core,Proteins, Viral Core,Proteins, Virus Core
D014764 Viral Proteins Proteins found in any species of virus. Gene Products, Viral,Viral Gene Products,Viral Gene Proteins,Viral Protein,Protein, Viral,Proteins, Viral

Related Publications

K H Chau, and G J Dawson, and I K Mushahwar, and R A Gutierrez, and R G Johnson, and R R Lesniewski, and L Mattsson, and O Weiland
Development of antibody to hepatitis C virus (HCV) in acute and chronic non-A, non-B post-transfusion hepatitis.
July 1992, European journal of epidemiology,
K H Chau, and G J Dawson, and I K Mushahwar, and R A Gutierrez, and R G Johnson, and R R Lesniewski, and L Mattsson, and O Weiland
Hepatitis C virus antibody response in acute and chronic non-A, non-B hepatitis.
January 1992, Nephron,
K H Chau, and G J Dawson, and I K Mushahwar, and R A Gutierrez, and R G Johnson, and R R Lesniewski, and L Mattsson, and O Weiland
IgM antibody to hepatitis C virus in acute and chronic hepatitis C.
July 1991, Hepatology (Baltimore, Md.),
K H Chau, and G J Dawson, and I K Mushahwar, and R A Gutierrez, and R G Johnson, and R R Lesniewski, and L Mattsson, and O Weiland
Detection of antibody to hepatitis C virus in prospectively followed transfusion recipients with acute and chronic non-A, non-B hepatitis.
November 1989, The New England journal of medicine,
K H Chau, and G J Dawson, and I K Mushahwar, and R A Gutierrez, and R G Johnson, and R R Lesniewski, and L Mattsson, and O Weiland
Antibody to hepatitis C virus in post-transfusion hepatitis.
February 1991, Annals of internal medicine,
K H Chau, and G J Dawson, and I K Mushahwar, and R A Gutierrez, and R G Johnson, and R R Lesniewski, and L Mattsson, and O Weiland
Antibodies to hepatitis C virus in non-A, non-B post-transfusion and cryptogenetic chronic liver disease.
September 1989, Lancet (London, England),
K H Chau, and G J Dawson, and I K Mushahwar, and R A Gutierrez, and R G Johnson, and R R Lesniewski, and L Mattsson, and O Weiland
IgM-antibody response to the hepatitis B core antigen in acute and chronic hepatitis B.
April 1981, The Journal of hygiene,
K H Chau, and G J Dawson, and I K Mushahwar, and R A Gutierrez, and R G Johnson, and R R Lesniewski, and L Mattsson, and O Weiland
[Immunologic changes in chronic post-transfusion positive hepatitis C and non-A non-B non-C hepatitis].
November 1994, Revista espanola de enfermedades digestivas,
K H Chau, and G J Dawson, and I K Mushahwar, and R A Gutierrez, and R G Johnson, and R R Lesniewski, and L Mattsson, and O Weiland
[Post-transfusion acute non-A, non-B hepatitis].
December 1988, Nihon rinsho. Japanese journal of clinical medicine,
K H Chau, and G J Dawson, and I K Mushahwar, and R A Gutierrez, and R G Johnson, and R R Lesniewski, and L Mattsson, and O Weiland
Chronic hepatitis after overt acute non-A, non-B post-transfusion hepatitis in Taiwan.
June 1982, Taiwan yi xue hui za zhi. Journal of the Formosan Medical Association,
Copied contents to your clipboard!